2-methoxy-1-(1-methyl-1H-pyrazol-5-yl)ethanone, 95.0%, 5g

5-(2,3-dihydro-1,4-benzodioxin-2-yl)-1,3,4-oxadiazol-2-amine, 95.0%, 250mg

(3-tert-Butoxycarbonylamino-pyrrolidin-1-yl)-acetic acid, 2.5g

[[(3,5-Dimethyl-1H-pyrrol-2-yl)(3,5-dimethyl-2H-pyrrol-2-ylidene)methyl]methane](difluoroborane) (purified by sublimation)>99.5%(GC)1g

4,4,5,5-TETRAMETHYL-2-(1-PHENYLCYCLOPROPYL)-1,3,2-DIOXABOROLANE, 95.0%, 250mg

8-Methyl-2-(p-tolyl)imidazo[1,2-a]pyridine, 98%, 250mg

RuPhos Pd G1, 98%, 500mg

METHYL 2-[4-(-2-PYRIMIDYL)-1-PIPERAZINYL]ACETATE, 95.0%, 1g

3,7-Dibromo-5,5-dimethyl-5H-dibenzo[b,d]silole, 95.0%, 100mg

Methyl 4-amino-3,5-dibromobenzoate, 98%, 5g

5-Bromo-2-fluoro-3-isopropoxypyridine, 95+%, 1g

3-(T-Butyldimethylsiloxy)propan-1-ol, 95%, 100g

H-Glu-OMe, 95%, 100g